• Cy3-UTP: Illuminating RNA Trafficking and Quantitative De...

  2025-09-26

  Explore how Cy3-UTP, a photostable fluorescent RNA labeling reagent, enables quantitative, mechanistic studies of RNA trafficking and nanoparticle delivery. Unlock unique strategies for tracking RNA dynamics beyond conventional imaging.

• X-press Tag Peptide: Enabling Precision in Post-Translati...

  2025-09-25

  Discover how X-press Tag Peptide advances protein purification and post-translational modification studies. This in-depth review explores its unique features, solubility, and applications in probing neddylation and mTORC1 signaling, setting it apart from standard protein purification tag peptides.

• L1023 Anti-Cancer Compound Library: Integrative Platforms...

  2025-09-24

  Explore how the L1023 Anti-Cancer Compound Library revolutionizes cancer research with its pathway-driven, cell-permeable compounds for high-throughput screening. Discover new perspectives on mechanism-based target identification and advanced applications in precision oncology.

• PD 0332991 (Palbociclib) HCl: Distinct Mechanisms of Cell...

  2025-09-23

  Explore how PD 0332991 (Palbociclib) HCl, a selective CDK4/6 inhibitor, mediates tumor growth suppression and cell cycle G1 phase arrest in breast cancer and multiple myeloma research. This article uniquely integrates recent insights on apoptosis signaling independent of transcriptional inhibition.

• Various compounds have been designed

  2025-03-03

  

  Various compounds have been designed to inhibit aldose reductase (AR) [12]. These compounds can be classified into two main categories, the first category comprises those containing a carboxylic SUMO Protease cleavage moiety, for example, 3-thiazolidineacetic acid derivative, which has been reporte

• Gliomas and Aldehyde Dehydrogenase Aldehyde dehydrogenases A

  2025-03-03

  

  Gliomas and Aldehyde Dehydrogenase Aldehyde dehydrogenases (ALDHs) are key metabolic enzymes involved in regulation of glycolysis/gluconeogenesis pathways as well as in the detoxification of endogenous and exogenous aldehydes, regulating cell function and homeostasis. ALDHs play important roles in

• Control of retinal vascularization during development and

  2025-03-03

  

  Control of retinal vascularization during development and OIR likely involves close interactions among endothelial cells, neurons and glial procyanidin supplement (microglial and astrocytes) (see Fig. 2). In particular, the interaction between endothelial tip cells and astrocytes plays a critical r

• Silicristin br Conflict of interest statement br Benign pros

  2025-03-03

  

  Conflict of interest statement Benign prostatic hyperplasia (BPH) is a highly complex process characterized by an increased number of epithelial and stromal Silicristin in the transition zone. , , Autopsy studies by McNeal detail the evolution of histological changes within these 2 cellular c

• br Conclusion br Conflicts of interest

  2025-03-03

  

  Conclusion Conflicts of interest Introduction RNA interference is a specific post-transcriptional gene silencing mechanism within a cell via the transfection of microRNAs (miRNA), exogenous small interfering RNAs (siRNA) or small hairpin RNAs (shRNA) [1–3]. Transfection of shRNA can be done

• The present study showed for the first time that hirsutine

  2025-03-03

  

  The present study showed, for the first time, that hirsutine, hirsuteine, rhynchophylline, isorhynchophylline, corynoxeine, and isocorynoxeine in yokukansan can inhibit the 5-HT3 receptor current. These data indicate that part of the effect of yokukansan against the behavioral and psychological symp

• Having established the structural requirements for potency i

  2025-03-03

  

  Having established the structural requirements for potency in both the biochemical and biomarker (CRA) assays, we evaluated key compounds in the metabolic stability assay. Disappointingly, we found that all compounds had high intrinsic clearances in mouse microsomes. To ascertain whether the in vitr

• br Introduction Stroke is a devastating condition that

  2025-03-03

  

  Introduction Stroke is a devastating condition that causes cognitive and motor dysfunction, neurodegenerative diseases and even acute death, and is a leading cause of mortality and morbidity worldwide (Chen et al., 2014a, Wang et al., 2016). Thus, exploration or identification of novel therapeuti

• To help ensure the fidelity of

  2025-03-03

  

  To help ensure the fidelity of mitosis and cytokinesis cells monitor these processes and delay cell cycle progression in response to certain defects. The spindle assembly checkpoint (SAC) is a surveillance system which delays cas9 protein onset until a bipolar spindle has been correctly assembled (L

• Potassium channel modulator Calcineurin has been established

  2025-03-01

  

  Calcineurin has been established to be a ubiquitous Ca2+-activated serine phosphatase in the nervous system (Pyrzynska et al., 2001). It has been reported that the activation of calcineurin protects aromatase from autophagy-mediated protein degradation, implying that calcineurin-dependent dephosphor

• Most of lipid lowering agents have many therapeutic problems

  2025-03-01

  

  Most of lipid-lowering agents have many therapeutic problems with severe side effects, while dietary fibers as lipid lowering therapy are safer. Chitosan (CS) is a dietary fiber biodegradable, biocompatible and has many health benefits including wound healing, antiinflammatory, anti-cancers, immune-

16276 records 9/1086 page Previous Next First page 上5页 678910 下5页 Last page